259 related articles for article (PubMed ID: 33589779)
21. CD38 Deficiency Protects Mouse Retinal Ganglion Cells Through Activating the NAD+/Sirt1 Pathway in Ischemia-Reperfusion and Optic Nerve Crush Models.
Pang Y; Hu H; Xu K; Cao T; Wang Z; Nie J; Zheng H; Luo H; Wang F; Xiong C; Deng KY; Xin HB; Zhang X
Invest Ophthalmol Vis Sci; 2024 May; 65(5):36. PubMed ID: 38776115
[TBL] [Abstract][Full Text] [Related]
22. AAV-mediated and pharmacological induction of Hsp70 expression stimulates survival of retinal ganglion cells following axonal injury.
Kwong JM; Gu L; Nassiri N; Bekerman V; Kumar-Singh R; Rhee KD; Yang XJ; Hauswirth WW; Caprioli J; Piri N
Gene Ther; 2015 Feb; 22(2):138-45. PubMed ID: 25427613
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the uniform field electroretinogram for mouse retinal ganglion cell functional analysis.
Lagali PS; Shanmugalingam U; Baker AN; Mezey N; Smith PD; Coupland SG; Tsilfidis C
Doc Ophthalmol; 2023 Aug; 147(1):29-43. PubMed ID: 37106219
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine 1-phosphate receptor 1 is required for retinal ganglion cell survival after optic nerve trauma.
Joly S; Pernet V
J Neurochem; 2016 Aug; 138(4):571-86. PubMed ID: 27309795
[TBL] [Abstract][Full Text] [Related]
25. Effect of intravitreal injection of bevacizumab on optic nerve head leakage and retinal ganglion cell survival in a mouse model of optic nerve crush.
Rappoport D; Morzaev D; Weiss S; Vieyra M; Nicholson JD; Leiba H; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8160-71. PubMed ID: 24168994
[TBL] [Abstract][Full Text] [Related]
26. AAV2-Mediated Transduction of the Mouse Retina After Optic Nerve Injury.
Nickells RW; Schmitt HM; Maes ME; Schlamp CL
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6091-6104. PubMed ID: 29204649
[TBL] [Abstract][Full Text] [Related]
27. The Susceptibility of Retinal Ganglion Cells to Optic Nerve Injury is Type Specific.
Yang N; Young BK; Wang P; Tian N
Cells; 2020 Mar; 9(3):. PubMed ID: 32164319
[TBL] [Abstract][Full Text] [Related]
28. Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy.
Tse BC; Dvoriantchikova G; Tao W; Gallo RA; Lee JY; Pappas S; Brambilla R; Ivanov D; Tse DT; Pelaez D
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2905-2912. PubMed ID: 30025145
[TBL] [Abstract][Full Text] [Related]
29. Ecel1 Knockdown With an AAV2-Mediated CRISPR/Cas9 System Promotes Optic Nerve Damage-Induced RGC Death in the Mouse Retina.
Sato K; Shiga Y; Nakagawa Y; Fujita K; Nishiguchi KM; Tawarayama H; Murayama N; Maekawa S; Yabana T; Omodaka K; Katayama S; Feng Q; Tsuda S; Nakazawa T
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3943-3951. PubMed ID: 30073365
[TBL] [Abstract][Full Text] [Related]
30. Molecular, anatomical and functional changes in the retinal ganglion cells after optic nerve crush in mice.
Yukita M; Machida S; Nishiguchi KM; Tsuda S; Yokoyama Y; Yasuda M; Maruyama K; Nakazawa T
Doc Ophthalmol; 2015 Apr; 130(2):149-56. PubMed ID: 25560383
[TBL] [Abstract][Full Text] [Related]
31. Differential protection of injured retinal ganglion cell dendrites by brimonidine.
Lindsey JD; Duong-Polk KX; Hammond D; Chindasub P; Leung CK; Weinreb RN
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1789-804. PubMed ID: 25634981
[TBL] [Abstract][Full Text] [Related]
32. Neuritin 1 promotes retinal ganglion cell survival and axonal regeneration following optic nerve crush.
Sharma TP; Liu Y; Wordinger RJ; Pang IH; Clark AF
Cell Death Dis; 2015 Feb; 6(2):e1661. PubMed ID: 25719245
[TBL] [Abstract][Full Text] [Related]
33. Optic Nerve Crush in Mice to Study Retinal Ganglion Cell Survival and Regeneration.
Cameron EG; Xia X; Galvao J; Ashouri M; Kapiloff MS; Goldberg JL
Bio Protoc; 2020 Mar; 10(6):. PubMed ID: 32368566
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective Effects of Human Serum Albumin Nanoparticles Loaded With Brimonidine on Retinal Ganglion Cells in Optic Nerve Crush Model.
Kim KE; Jang I; Moon H; Kim YJ; Jeoung JW; Park KH; Kim H
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5641-9. PubMed ID: 26313300
[TBL] [Abstract][Full Text] [Related]
35. Real-time imaging of RGC death with a cell-impermeable nucleic acid dyeing compound after optic nerve crush in a murine model.
Tsuda S; Tanaka Y; Kunikata H; Yokoyama Y; Yasuda M; Ito A; Nakazawa T
Exp Eye Res; 2016 May; 146():179-188. PubMed ID: 27013099
[TBL] [Abstract][Full Text] [Related]
36. Assessment of outer retinal thickness and function in mice after experimental optic nerve trauma.
Lypka KR; Carmy-Bennun T; Garces KN; Venanzi AW; Hackam AS
BMC Ophthalmol; 2022 Dec; 22(1):502. PubMed ID: 36539722
[TBL] [Abstract][Full Text] [Related]
37. Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury.
Syc-Mazurek SB; Fernandes KA; Wilson MP; Shrager P; Libby RT
Mol Neurodegener; 2017 Oct; 12(1):71. PubMed ID: 28969695
[TBL] [Abstract][Full Text] [Related]
38. Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition.
Yao K; Mou Q; Lou X; Ye M; Zhao B; Hu Y; Luo J; Zhang H; Li X; Zhao Y
J Neuroinflammation; 2023 Sep; 20(1):202. PubMed ID: 37670386
[TBL] [Abstract][Full Text] [Related]
39. Human Periodontal Ligament-Derived Stem Cells Promote Retinal Ganglion Cell Survival and Axon Regeneration After Optic Nerve Injury.
Cen LP; Ng TK; Liang JJ; Zhuang X; Yao X; Yam GH; Chen H; Cheung HS; Zhang M; Pang CP
Stem Cells; 2018 Jun; 36(6):844-855. PubMed ID: 29476565
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.
Osborne A; Khatib TZ; Songra L; Barber AC; Hall K; Kong GYX; Widdowson PS; Martin KR
Cell Death Dis; 2018 Sep; 9(10):1007. PubMed ID: 30258047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
